in Short

Rwanda : BioNTech vaccine manufacturing plant to be launched next month

The state-of-the-art manufacturing plant for mRNA-based vaccines, developped by German biotechnology company BioNTech, will be inaugurated on December 18.

A memorandum of understanding signed between the two parties in 2021 led to the establishment of a BioNTech facility in the Special Economic Zone in Gasabo District in June 2022.

The Rwanda-based facility covers an area of about 30,000 square metres. It is equipped with BioNTainers (for the production of mRNA and formulated bulk drug products).

Articles similaires

Laisser un commentaire

Bouton retour en haut de la page